Birgitta Dietz

Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV

Kit N. Simpson, Alvin Strassburger, Walter J. Jones et al. · PharmacoEconomics · 2009 · 70 citations

Engineering, Infectious Disease Control, Infectious Diseases +14

Improvement and longterm maintenance of quality of life during treatment with adalimumab in severe rheumatoid arthritis.

Thomas Mittendorf, Birgitta Dietz, Raimund Sterz et al. · PubMed · 2007 · 35 citations

Medicine, Internal Medicine, End-of-life Care +16

Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy

Rukmini Rajagopalan, David Laitinen, Birgitta Dietz · AIDS Care · 2008 · 29 citations · Full text

Pharmacy, Internal Medicine, Health Assessment +10

Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States

Kit N. Simpson, Pamela P. Pei, Jörgen Möller et al. · PharmacoEconomics · 2013 · 24 citations

Pharmacy, Infectious Diseases, Pharmacoeconomics +12

Cost Effectiveness of Lopinavir/Ritonavir Tablets Compared with Atazanavir plus Ritonavir in Antiretroviral-Experienced Patients in the UK, France, Italy and Spain

Kit N. Simpson, Walter J. Jones, Rukmini Rajagopalan et al. · Clinical Drug Investigation · 2007 · 24 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +12